众合科技(000925)
MegaLife Health

Breakthroughs in each stage will bring more than 10 times the value added. Overall intensive operation and production to improve efficiency.



Medical Device Value Chain - CDMO Full Cycle Accelerated Industrialization Platform






CDMO Solution for InnoStella MedTech


CDMO Solution for InnoStella MedTech


Differentiated development strategy: attract global intellectual property and technical talents to come to China and push Chinese intelligent manufacturing to the world market



Global → Platform → China: Technology and Talent Introduction

  • Carry out further development and adaptation research, clinical trials, and NMPA certification. 

  • Develop global production plans based on enterprise needs.

  • Implement the construction of a unified marketing, after-sales, and information feedback system.

China → Platform → Global: Chinese Medical Enterprises Going Abroad

  • By establishing bridges, incubating, and accelerating the technical feasibility of medical products in China, including production, manufacturing, research and development, clinical testing, etc., and improving market access, CE and FDA certification, as well as legal regulations.

  • Through a global market network initiated by various sub-centers, promote commercially transformed specific products developed in China worldwide.

  • Provide sustainable support policies, technical assistance, and corresponding financial solutions for enterprises on the central platform.